Magazine: How non-invasive NASH testing can move the needle

In this month’s issue, we examine the future of two indications with high unmet need – amyotrophic lateral sclerosis (ALS) and non-alcoholic steatohepatitis (NASH) – through the lens of advances in medical technologies that target to improve the quality of life of patients or to accelerate the development of therapies via a less cumbersome diagnostic method.

On World IVF Day, in another forward-looking analysis, we look at the assisted reproductive technology sector and the investment opportunities it presents.

Also in this issue, we look at the latest trends in the medical applications of nanotechnology.

Elsewhere, coinciding with the World Health Organization’s recent declaration of monkeypox as a global health emergency, we discuss new tests being developed and how increased surveillance can boost this market. In a commentary, Matt Barnes shares his vision for an IT network architecture suited to the digital journey of the NHS.

Read the latest issue of Medical Technology for all this and more pharmaceutical industry news, insights, data and analysis.

You can also sign up here to receive email notifications when a new issue is available.

Related companies